Brief: Median Technologies Says Confirmed As Vendor By Undisclosed Pharmaceutical Company
16/09/2021 17:35
Sept 16 (Reuters) - Median Technologies SA ALMDT.PA :
* CONFIRMED AS A PREFERRED VENDOR BY ONE OF TOP 3
PHARMACEUTICAL
COMPANIES IN WORLD
* SELECTED TO IMPLEMENT THE CONTRACTOR'S CLINICAL TRIAL
IMAGING
STRATEGY ON SOME KEY ONCOLOGY INDICATIONS
* MEDIAN TECHNOLOGIES CANNOT DISCLOSE NAME OF CLIENT NOR
TERMS OF
AGREEMENT
Source text for Eikon: ID:nBw4PLHyXa
Further company coverage: ALMDT.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Median Technologies SA
See all newsBrief: Median Technologies Forms Strategic Review Committee To Consider iCRO Separation, US Listing
France's Median Technologies H1 order backlog rises on demand from biopharmaceutical clients
Brief: Median Technologies H1 Revenue EUR 11.8 Million
Brief: Median Launches Eur 40 Mln Capital Raise To Fund Eyonis Rollout, Extend Runway To H1 2028
Brief: Median Technologies Reports FY Revenue EUR 23.5 Million